S-280 , 44th Parliament, 1st session Monday, November 22, 2021, to present
An Act respecting a national framework on sickle cell disease
Short title:
National Framework on Sickle Cell Disease Act
Summary
Current status
At consideration in committee in the Senate
Latest activity
Referral to committee on Tuesday, June 4, 2024 (Senate)
Progress
Senate
End of stage activity
Introduction and first reading, Tuesday, November 7, 2023
Chamber sittings
Sitting date | Debates (Hansard) |
---|---|
Tuesday, November 7, 2023 |
End of stage activities
Second reading, Tuesday, June 4, 2024
Referral to committee, Tuesday, June 4, 2024
Chamber sittings
Sitting date | Debates (Hansard) |
---|---|
Tuesday, November 28, 2023 |
|
Tuesday, December 12, 2023 |
|
Tuesday, February 6, 2024 |
|
Wednesday, February 7, 2024 |
|
Thursday, February 15, 2024 |
|
Tuesday, April 9, 2024 |
|
Tuesday, June 4, 2024 |
Consideration in committee
No activity
Report stage
Not reached
Third reading
Not reached
First reading
Not reached
Second reading
Not reached
Consideration in committee
Not reached
Report stage
Not reached
Third reading
Not reached
Details
Recorded votes
House of Commons
There are currently no recorded votes for this bill.
Senate
To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.Speaker's rulings and statements
There are currently no Speaker's rulings and statements.
Major speeches at second reading
Senate
Speech date | Speech | Senator |
---|---|---|
Tuesday, November 28, 2023 | Sponsor’s speech(Sitting 163) | Marie-Françoise Mégie (Independent Senators Group) |
Thursday, February 15, 2024 | Response speech(Sitting 180) | Sharon Burey (Canadian Senators Group) |
About
Similar bills
Similar bills introduced in a previous Parliament
40th Parliament, 3rd session
From the Library of Parliament
The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.